SMAD7 and endometrial cancer: In conclusion, we show that hsa_circ_0001860 plays an important role in the resistance of EC to MPA through miR-520h/Smad7 axis, and it could be developed into a novel marker and therapeutic target for MPA-resistant endometrial cancer.